OC
ALAB icon

Oppenheimer & Co’s Astera Labs ALAB Stock Holding History

Oppenheimer & Co’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
3,841
+975
+34% +$259K 0.02% 667
2026
Q1 		$314K Buy
+2,866
New +$408K ﹤0.01% 1368
2025
Q1 		– Sell
-26,242
Closed -$3.48M – 1682
2024
Q4 		$3.48M Buy
+26,242
New +$2.46M 0.05% 377

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oppenheimer & Co's ALAB Position: Q2 2026 in Review

Oppenheimer & Co increased its Astera Labs (ALAB) stake by 34% in Q2 2026, buying an estimated $259K and bringing the position to 3,841 shares worth $1.86M. The position accounts for 0.02% of the portfolio, ranked #667.

Oppenheimer & Co first reported a position in ALAB in Q4 2024 and has held it in 3 quarters since. The position peaked at $3.48M in Q4 2024. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Oppenheimer & Co held 3,841 shares of Astera Labs worth $1.86M as of Q2 2026.
  • Oppenheimer & Co bought 975 Astera Labs shares in Q2 2026, an estimated $259K.
  • Astera Labs made up 0.02% of Oppenheimer & Co's portfolio in Q2 2026, its #667 holding.
  • Oppenheimer & Co first reported a position in Astera Labs in Q4 2024 and has held it in 3 quarters since.
  • Oppenheimer & Co's Astera Labs position peaked at $3.48M in Q4 2024.
  • 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.